Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

631
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
631
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

419
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2024 Thai guidelines on the treatment of hypertension.

Asian biomedicine : research, reviews and news·2026
Same author

Early unfavorable outcomes of second-trimester selective feticide for complicated monochorionic twins: single-operator experiences.

Journal of perinatal medicine·2025
Same author

Clinical-grade allogeneic amniotic fluid stem cell banking: quality control for therapeutic applications and drug development.

Stem cell research & therapy·2025
Same author

COSMO-RS assisted selection of eutectic solvents for lignin dissolution and enhanced laccase activity.

International journal of biological macromolecules·2025
Same author

Effect of aspirin on small for gestational age neonates in pregnancies at high-risk for preeclampsia: a secondary analysis of a cluster randomised clinical trial.

The Lancet regional health. Western Pacific·2025
Same author

Layer-by-layer assembly: advancing skin repair, one layer at a time.

RSC advances·2025

Related Experiment Video

Updated: Mar 14, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.8K

Cesarean section: the pediatricians' views.

Manuel R G Carrapato1,2, Ana M Ferreira1, Tuangsit Wataganara3

  • 1a Pediatrics/Neonatal Department, S. Sebastião Hospital , Santa Maria da Feira , Portugal.

The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
|September 24, 2016
PubMed
Summary

Cesarean sections (CS) are increasing, but their long-term benefits, especially for preterm infants, are debated. Decisions should prioritize the net clinical benefit for mother and child.

Keywords:
Cesarean sectionimmediate and long-term outcomespediatricians’ views

More Related Videos

External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

16.0K
Surgical Management of Meatal Stenosis with Meatoplasty
04:53

Surgical Management of Meatal Stenosis with Meatoplasty

Published on: November 30, 2010

55.4K

Related Experiment Videos

Last Updated: Mar 14, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.8K
External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

16.0K
Surgical Management of Meatal Stenosis with Meatoplasty
04:53

Surgical Management of Meatal Stenosis with Meatoplasty

Published on: November 30, 2010

55.4K

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Pediatrics

Background:

  • Cesarean sections (CS) have seen a significant rise, influenced by improved safety and maternal preference.
  • CS for nonmedical reasons (maternal request) sparks considerable scientific, legal, and ethical debate.
  • The pediatrician's perspective is crucial in evaluating the implications of CS on neonates.

Purpose of the Study:

  • To critically evaluate the pediatric implications of cesarean sections.
  • To examine the evidence regarding neonatal and long-term outcomes following CS, particularly in preterm infants.
  • To discuss the ethical considerations and clinical benefits of CS, including those requested by mothers.

Main Methods:

  • Review of existing literature on neonatal outcomes following CS versus vaginal delivery.
  • Analysis of studies examining mid- and long-term health effects in children born via CS.
  • Consideration of the impact of CS on the neonatal microbiome.

Main Results:

  • Immediate neonatal issues are recognized, but mid- and long-term outcomes for preterm infants after CS are not consistently advantageous compared to vaginal delivery.
  • Neonates born via CS may experience altered gut microbiome colonization due to reduced exposure to maternal flora.
  • Contradictory findings exist regarding the long-term health advantages of CS for preterm neonates.

Conclusions:

  • Mode of delivery for preterm infants should be individualized based on specific circumstances, not solely on CS.
  • The potential long-term health consequences of altered neonatal microbiome following CS warrant further investigation.
  • Decisions regarding CS should be based on a comprehensive assessment of the net clinical benefit for the mother, child, and future adult.